Looking forward to James presenting the shareholder update today at 1pm
In this session, I will discuss:
- What to expect from our Phase 2a trial, with First Patient In and Dosed (FPID) anticipated in the coming weeks.
- How our promising Phase 1b results could help turn our Phase 2 trial into a registrational study.
- The significance of the Fast Track Designation granted by the FDA in April, and what it means for our potential accelerated path to commercialisation.
Looking forward to James presenting the shareholder update today...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.002(4.65%) |
Mkt cap ! $40.05M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.1¢ | $73.49K | 1.764M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1701798 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 236496 | 1 |
View Market Depth
| Last trade - 15.59pm 08/08/2025 (20 minute delay) ? |
| PTX (ASX) Chart |